51314-72-8Relevant academic research and scientific papers
IGF-1R SIGNALING PATHWAY INHIBITORS USEFUL IN THE TREATMENT OF NEURODEGENERATIVE DISEASES
-
Paragraph 0251; 0252; 0253; 0254; 0255, (2016/07/05)
The present invention provides compounds acting as Insulin/IGF signaling modulators useful in the treatment of neurodegenerative diseases and disorders. The invention provides pharmaceutical compositions including such compounds, and methods of using thes
2 - (2 - PHENYLETHENYL) - 1, 3 -BENZOTHIAZINE DERIVATIVES USEFUL FOR THE TREATMENT CANCER
-
Page/Page column 43, (2012/07/14)
of formula 4 The present invention provides compounds of formula (1) acting as protein kinase (PK) and receptor kinase (RK) signaling modulators. The invention further provides methods of their preparation, pharmaceutical compositions including such compo
NOVEL MODULATORS OF PROTEIN KINASE SIGNALING
-
Page/Page column 44, 47, (2009/12/28)
The present invention provides new tyrphostin derivatives acting as protein kinase (PK) and receptor kinase (RK) signaling modulators. The invention further provides methods of their preparation, pharmaceutical compositions including such compounds, and m
NOVEL PROTEIN KINASE MODULATORS AND THERAPEUTIC USES THEREOF
-
Page/Page column 36, (2008/12/06)
The present invention provides new tyrphostin derivatives acting as substrate competitive protein tyrosine kinase (PTK) inhibitors and receptor tyrosine kinase (RTK) inhibitors, methods of their preparation, pharmaceutical compositions including such comp
